INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 106 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,794,000 | -25.8% | 258,467 | -0.4% | 0.00% | -33.3% |
| Q3 2016 | $2,418,000 | +0.7% | 259,397 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $2,402,000 | +5.5% | 259,906 | -0.5% | 0.00% | 0.0% |
| Q1 2016 | $2,276,000 | +32.5% | 261,301 | +2.2% | 0.00% | +50.0% |
| Q4 2015 | $1,718,000 | +16.1% | 255,636 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $1,480,000 | -29.8% | 256,114 | -0.9% | 0.00% | -33.3% |
| Q2 2015 | $2,109,000 | +44.7% | 258,415 | +44.7% | 0.00% | +50.0% |
| Q1 2015 | $1,457,000 | -10.0% | 178,606 | +1.3% | 0.00% | 0.0% |
| Q4 2014 | $1,619,000 | -8.2% | 176,391 | -1.5% | 0.00% | 0.0% |
| Q3 2014 | $1,763,000 | -7.7% | 179,034 | +1.3% | 0.00% | -33.3% |
| Q2 2014 | $1,910,000 | – | 176,686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
| STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
| Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
| WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
| Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
| Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
| EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
| Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
| Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |